aztreonam has been researched along with carumonam in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 66 (77.65) | 18.7374 |
1990's | 12 (14.12) | 18.2507 |
2000's | 4 (4.71) | 29.6817 |
2010's | 3 (3.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Hayashi-Nishino, M; Nishino, K; Yamaguchi, A; Yamasaki, S | 1 |
Bermingham, A; Blais, J; Capka, V; Cariaga, T; Casarez, A; Colvin, R; Dean, CR; Fekete, A; Gong, W; Growcott, E; Guo, H; Jones, AK; Li, C; Li, F; Lin, X; Lindvall, M; Lopez, S; McKenney, D; Metzger, L; Moser, HE; Prathapam, R; Rasper, D; Reck, F; Rudewicz, P; Sethuraman, V; Shaul, J; Shen, X; Simmons, RL; Tang, D; Tashiro, K; Tjandra, M; Turner, N; Uehara, T; Vitt, C; Whitebread, S; Yifru, A; Zang, X; Zhu, Q | 1 |
Hibi, S; Imashuku, S; Nakajima, F; Takaya, K; Todo, S | 1 |
Keller, N; Overbeek, BP; Raponi, G; Rozenberg-Arska, M; Torensma, R; Verhoef, J | 1 |
Bertasso, A; Georgopapadakou, NH | 1 |
Deguchi, N; Fugono, T; Konishi, K; Saruta, T; Suzuki, H | 1 |
Inoue, M; Matsuda, K; Mitsuhashi, S; Nakagawa, S; Sanada, M | 1 |
Ihara, Y; Iwao, N; Kishimoto, T; Kuroda, H; Mizutani, S; Nakano, E; Seguchi, T; Sonoda, T; Takatera, H; Yano, H | 1 |
Kuzui, H; Murakami, T; Nishino, T; Obana, Y | 1 |
Hubrechts, JM; Nulens, E; Nyssen, HJ; Roebben, E; Vanhoof, R | 1 |
Hirano, J; Hirano, K; Imamura, A; Ishii, N; Kakizaki, H; Mitobe, K; Murakami, S; Saito, M; Suzuki, K; Takamizawa, A | 1 |
Fujita, N; Inaba, T; Itoh, K; Murakami, S; Nakagawa, M; Oku, N; Shimazaki, C; Ura, Y | 1 |
Dekker, BA; Lippe, W; Overbeek, BP; Schellekens, JF; Verhoef, J | 1 |
Gilpin, C; Hempenstall, J; Nimmo, G; Weir, L; Whitby, M | 1 |
Banken, L; Patel, IH; Portmann, R; Soni, PP; Suter, K; Weidekamm, E | 1 |
Braveny, I; Machka, K; Milatovic, D | 1 |
Cassano, K; Edelstein, H; McCabe, R; Oster, S | 1 |
Saito, A | 1 |
Benson, CA; Trenholme, GM; Walton, FE | 1 |
Imada, A; Kondo, M; Nakao, M | 1 |
Donato, JB; Joseph, WS; LeFrock, JL; McCloskey, RV; Smith, BR; Weber, SJ | 1 |
Kayser, FH; Vurma-Rapp, U | 1 |
Barry, AL; Fuchs, PC; Jones, RN; Packer, RR; Thornsberry, C | 1 |
Abe, S; Kawakami, Y; Koroku, T; Nakayama, I; Onodera, T; Saito, A; Shimada, K; Suzuki, A; Tomizawa, M; Yasuda, N | 1 |
Appelbaum, PC; Spangler, SK; Tamarree, T | 1 |
Kafetzis, DA; Legakis, NJ | 1 |
Hohl, P; von Graevenitz, A; Zollinger-Iten, J | 1 |
Deguchi, K; Fukayama, S; Kato, M; Koguchi, M; Nakane, Y; Nishimura, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Blakemore, PH; Drabu, YJ; Mehtar, S | 1 |
Cocuzza, CE; Mattina, R; Raimondi, A | 1 |
Box, A; Rozenberg-Arska, M; Verhoef, J; Veringa, E | 1 |
Croize, J; Le Noc, D; Le Noc, P | 1 |
Fournier, P; Labia, R; Morand, A; Philippin, JL; Pitton, JS | 1 |
Ahmet, Z; Houang, E | 1 |
Baquero, F; Cisterna, R; García de Lomas, J; García-Rodriguez, J; Gobernado, M; Gómez Lus, R; Martín-Luengo, F; Perea, E; Piedrola, G; Roy, C | 1 |
Frankenschmidt, A; Pelz, K; Westenfelder, M | 1 |
Bauernfeind, A; Denk, K; Grobecker, H; Kees, F; Naber, K | 1 |
Barclay, C; Casellas, J; Farinati, A; Hahn, LB; Iribarren, M; Traballi, C | 1 |
Bergeron, MG; Bérubé, D; LeBel, M; Panneton, AC; Vallée, F | 1 |
Bakker, LJ; Hoepelman, AI; Verhoef, J | 1 |
Imada, A; Kita, Y | 1 |
Endo, K; Irie, T; Okamoto, K; Sagara, M; Sekino, K; Takebe, K; Tamura, T; Uehara, O | 1 |
Houben, AW; Stobberingh, EE; van Boven, CP | 1 |
Bergeron, MG; Boucher, FD; Lavoie, GY | 1 |
Garcia, M; Landinez, R; Merino, C | 1 |
Hänninen, P; Huovinen, P; Kotilainen, P | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Duval, JR; Le Van Thoi, J; Soussy, CJ | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
Höffler, D; Koeppe, P; Strobel, K | 1 |
Hoepelman, IM; Rozenberg-Arska, M; Steyger, G; Verhoef, J | 1 |
Barclay, CA; Casellas, JM; Goldberg, M; Iribarren, MA; Traballi, CA | 1 |
Borobio, V; Garcia-Iglesias, MC; Pascual, A; Perea, EJ | 1 |
Mizuguchi, Y; Nikaido, Y; Yoshida, S | 1 |
Egger, HJ; Fischer, G | 1 |
Barry, AL; Jones, RN | 1 |
Dubach, UC; Egger, HJ; Frey, FJ; Horber, F; Probst, PJ; Stoeckel, K; Weidekamm, E | 1 |
Fugono, T; Imada, A; Kita, Y | 1 |
Mitani, M; Naeshiro, I; Tanayama, S; Torii, H; Yoshida, K | 1 |
Iida-Tanaka, K; Irino, S; Nagayama, A; Tanaka, T | 1 |
Itakura, K; Matsuhisa, Y; Umemoto, K; Usui, Y | 1 |
Imada, A; Kondo, M; Kuno, M; Okonogi, K; Yukishige, K | 1 |
Hamana, Y; Inoue, M; Matsuda, K; Mitsuhashi, S | 1 |
Campos, P; Martin-Luengo, F; Vera, A | 1 |
Chau, PY; Leung, YK; Livermore, DM; Ng, WW | 1 |
Foz, A; Roy, C; Segura, C; Teixell, M; Tirado, M | 1 |
Kohl, I; Then, RL | 1 |
Benonisen, E; Dibb, WL; Digranes, A; Salveson, A | 1 |
Huerre, M; Meyran, M; Thabaut, A | 1 |
Bremner, DA | 1 |
Angehrn, P | 1 |
Andrews, JM; Piddock, LJ; Wise, R | 1 |
Foz, A; Hermida, M; Reig, R; Roy, C; Segura, C; Teixell, M; Teruel, D | 1 |
Ashby, J; Garden, GM; McNulty, CA; Wise, R | 1 |
Fass, RJ; Helsel, VL | 1 |
Then, RL | 1 |
Egger, HJ; Stoeckel, K; Weidekamm, E; Ziegler, WH | 1 |
Frère, JM; Lamotte-Brasseur, J; Matagne, A | 1 |
De Sarro, A; De Sarro, GB; Imperatore, C; Naccari, F | 1 |
Giamarellou, H; Kanellakopoulou, K; Manta, M; Tsagaraki, C | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
Bulitta, JB; Drusano, GL; Duffull, SB; Holzgrabe, U; Kinzig, M; Landersdorfer, CB; Sörgel, F; Stephan, U | 1 |
Srinivas, NR | 1 |
2 review(s) available for aztreonam and carumonam
Article | Year |
---|---|
[Recombinant human granulocyte-colony stimulating factor (rhG-CSF) treatment for spleen abscess and periostitis in a patient with chronic granulomatous disease].
Topics: Abscess; Aztreonam; Ceftizoxime; Child; Chloramphenicol; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Granulomatous Disease, Chronic; Humans; Infusions, Intravenous; Male; Periostitis; Recombinant Proteins; Splenic Diseases | 1992 |
[Carumonam].
Topics: Animals; Aztreonam; Humans | 1988 |
11 trial(s) available for aztreonam and carumonam
Article | Year |
---|---|
Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.
Topics: Adult; Aztreonam; Drug Evaluation; Female; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Regression Analysis; Renal Dialysis | 1991 |
[Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection].
Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Cefotiam; Drug Synergism; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Urinary Tract Infections | 1991 |
[Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
Topics: Adult; Aged; Aged, 80 and over; Aztreonam; Chronic Disease; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Middle Aged; Urinary Tract Infections | 1990 |
Carumonam versus ceftazidime for urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidime; Drug Tolerance; Female; Humans; Male; Urinary Tract Infections | 1988 |
[Clinical evaluation of carumonam in chronic respiratory infections: double-blind study using cefoperazone as a positive control].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Cefoperazone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1987 |
Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic | 1987 |
Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotiam; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Random Allocation; Urinary Tract Infections | 1987 |
Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
Topics: Aged; Anti-Bacterial Agents; Aztreonam; Bacteria; Ceftazidime; Clinical Trials as Topic; Female; Humans; Male; Microbial Sensitivity Tests; Urinary Tract Infections | 1987 |
Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacteria; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Urinary Tract Infections | 1987 |
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Drug Evaluation; Female; Gentamicins; Humans; Injections, Intramuscular; Injections, Intravenous; Lactams; Male; Middle Aged; Prospective Studies; Random Allocation; Recurrence; Urinary Tract Infections | 1988 |
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Clinical Trials as Topic; Dialysis; Feces; Half-Life; Humans; Kidney Glomerulus; Kinetics; Male; Probenecid; Protein Binding; Ultrafiltration | 1984 |
72 other study(ies) available for aztreonam and carumonam
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Effect of NlpE overproduction on multidrug resistance in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Copper; Drug Resistance, Bacterial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; CHO Cells; Cricetulus; Drug Stability; Escherichia coli; Female; Humans; Meropenem; Mice; Microbial Sensitivity Tests; Molecular Structure; Monobactams; Pseudomonas aeruginosa; Receptors, GABA-A; Seizures; Structure-Activity Relationship; Thienamycins | 2018 |
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Blood Bactericidal Activity; Ceftriaxone; Ciprofloxacin; Complement System Proteins; Enzyme-Linked Immunosorbent Assay; Epitopes; Escherichia coli; Escherichia coli Infections; Female; Immunization; Immunoglobulin G; Immunoglobulin M; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Netilmicin; Opsonin Proteins; Phagocytosis | 1991 |
Effects of quinolones on nucleoid segregation in Escherichia coli.
Topics: Anti-Infective Agents; Aztreonam; Cell Nucleus; DNA, Bacterial; Dose-Response Relationship, Drug; Escherichia coli; Fleroxacin; Photomicrography | 1991 |
Preferential hydrolysis of cis configuration compounds at the 3,4 position of monobactams by beta-lactamase from Morganella morganii.
Topics: Aztreonam; beta-Lactamases; Cell Line; Gram-Negative Bacteria; Hydrolysis; Microbial Sensitivity Tests; Monobactams; Stereoisomerism; Structure-Activity Relationship | 1991 |
[Bacterial combination effect between carumonam and eight other antibiotics].
Topics: Animals; Aztreonam; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Female; Fosfomycin; Gentamicins; Mice; Piperacillin; Proteus vulgaris; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections | 1990 |
[Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Cephalothin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; In Vitro Techniques; Quinolones | 1990 |
[Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies].
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Clindamycin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged | 1990 |
Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Aztreonam; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Immunologic Techniques; Lactams; Mutation; O Antigens | 1987 |
Penetration of monobactam antibiotics (aztreonam, carumonam) into human prostatic tissue.
Topics: Aged; Aztreonam; Humans; Infusions, Intravenous; Male; Prostate | 1989 |
Multiple intravenous dose pharmacokinetic study of carumonam in healthy subjects.
Topics: Adult; Aztreonam; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Male | 1989 |
In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
Topics: Aminocoumarins; Anti-Bacterial Agents; Aztreonam; Bacteria; Cloxacillin; Coumarins; Drug Therapy, Combination; Enterobacter; Floxacillin; Glycopeptides; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia marcescens; Teicoplanin; Vancomycin | 1987 |
Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans | 1986 |
Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.
Topics: Anti-Bacterial Agents; Aztreonam; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1986 |
Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa | 1986 |
In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Drug Resistance, Microbial; Humans; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1986 |
The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ceftazidime; Chemical Phenomena; Chemistry; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrolysis; Immunodiffusion; In Vitro Techniques; Microbial Sensitivity Tests | 1986 |
Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Ofloxacin; Oxazines | 1988 |
Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftizoxime; Ciprofloxacin; Drug Therapy, Combination; Enterobacteriaceae; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1987 |
In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.
Topics: Anti-Bacterial Agents; Aztreonam; Enterobacteriaceae; Gram-Negative Bacteria; Lactams; Legionella; Microbial Sensitivity Tests | 1988 |
[Antibacterial activities of monobactams against fresh clinical isolates].
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Humans; Monobactams | 1988 |
Clinical efficacy of carumonam.
Topics: Aged; Aged, 80 and over; Aztreonam; Bacterial Infections; Female; Gram-Negative Aerobic Bacteria; Humans; Male; Middle Aged; Sepsis | 1988 |
Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefotetan; Ceftazidime; Ceftriaxone; Cephamycins; Drug Stability; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1988 |
Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Antigens, Surface; Aztreonam; Bacteriolysis; Blood Bactericidal Activity; Escherichia coli; Humans; Opsonin Proteins; Phagocytosis | 1988 |
[Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1987 |
[Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefotetan; Cefoxitin; Cephamycins; Imipenem; Klebsiella; Klebsiella pneumoniae; Plasmids; Thienamycins | 1987 |
Synergy study of carumonam and ceftazidime with aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Drug Combinations; Drug Synergism; Microbial Sensitivity Tests | 1987 |
Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Humans; Lactams; Male; Protein Binding | 1988 |
Mechanism of renal excretion of carumonam in rats, rabbits, dogs, and monkeys.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Dogs; Female; Kidney; Lactams; Macaca fascicularis; Male; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Probenecid; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1987 |
[Clinical study of carumonam].
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Female; Humans; Infusions, Intravenous; Lactams; Male; Middle Aged; Respiratory Tract Infections | 1987 |
In-vitro evaluation of carumonam (Ro 17-2301).
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1986 |
Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefixime; Cefotaxime; Enoxacin; Haemophilus influenzae; Leucomycins; Microbial Sensitivity Tests; Naphthyridines | 1987 |
In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1987 |
Carumonam in the treatment of severe and complicated urinary tract infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacteria; Female; Humans; Male; Urinary Tract Infections | 1987 |
The in-vitro activity and beta-lactamase stability of carumonam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Culture Media; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1986 |
[In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Cross Infection; Humans; Lactams; Microbial Sensitivity Tests | 1986 |
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Citrobacter; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas | 1986 |
Pharmacokinetics and dose recommendations of carumonam in renal failure.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Humans; Kidney Failure, Chronic; Kinetics; Lactams; Middle Aged | 1987 |
Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics.
Topics: Anti-Bacterial Agents; Aztreonam; Drug Interactions; Drug Resistance, Microbial; Gentamicins; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests | 1987 |
Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Microbial Sensitivity Tests; Regression Analysis | 1987 |
Comparative in-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Cephalosporins; Leucomycins; Microbial Sensitivity Tests | 1987 |
In vitro effects of monobactams on Legionella pneumophila.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Guinea Pigs; Legionella; Macrophages; Microbial Sensitivity Tests | 1987 |
Determination of the monocyclic beta-lactam antibiotic carumonam in plasma and urine by ion-pair and ion-suppression reversed-phase high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Temperature; Ultrafiltration | 1987 |
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
Topics: Anti-Bacterial Agents; Aztreonam; Culture Media; Gram-Negative Bacteria; Microbial Sensitivity Tests; Quality Control; Regression Analysis | 1987 |
Pharmacokinetics of carumonam in patients with renal insufficiency.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Kidney Failure, Chronic; Kinetics; Lactams; Liver Function Tests; Male; Middle Aged | 1986 |
Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bile; Chromatography, High Pressure Liquid; Dogs; Female; Kinetics; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Rabbits; Rats; Species Specificity; Tissue Distribution | 1986 |
Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Bile; Chromatography, Thin Layer; Dogs; Feces; Female; Male; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution | 1986 |
Enhanced bactericidal action of mouse macrophages by subinhibitory concentrations of monobactams.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Cells, Cultured; Macrophages; Mice; Mice, Inbred C3H; Microscopy, Electron; Muramidase; Stimulation, Chemical | 1986 |
Degradation kinetics of carumonam in aqueous solution.
Topics: Anti-Bacterial Agents; Aztreonam; Drug Stability; Kinetics; Lactams; Solutions | 1986 |
In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Stability; Female; Hydrolysis; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Protein Binding | 1985 |
In-vitro antibacterial activity of AMA-1080.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Kinetics; Microbial Sensitivity Tests; Time Factors | 1985 |
In vitro activity of azthreonam and Ro 17-2301 against multiresistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Aztreonam; Pseudomonas aeruginosa | 1985 |
In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 1985 |
[In vitro activity of Ro 17-2301, a new monobactam antibiotic].
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Drug Resistance; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1985 |
Affinity of carumonam for penicillin-binding proteins.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Binding, Competitive; Carboxypeptidases; Carrier Proteins; Cefotaxime; Ceftriaxone; Electrophoresis, Polyacrylamide Gel; Enterobacter; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
Topics: Acinetobacter; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Thienamycins | 1985 |
[Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Topics: Acinetobacter; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1985 |
In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 1985 |
Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Enterobacteriaceae; Escherichia coli Infections; Female; Hydrogen-Ion Concentration; Leukopenia; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pyelonephritis; Rats; Rats, Inbred Strains; Sepsis | 1985 |
The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Proteins; Carrier Proteins; Culture Media; Drug Resistance, Microbial; Gentamicins; Hexosyltransferases; Lactams; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1985 |
Activity of carumonam and aztreonam against Klebsiella species.
Topics: Anti-Bacterial Agents; Aztreonam; Klebsiella | 1985 |
Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Blister; Humans; Kinetics; Lactams; Male; Metabolic Clearance Rate | 1985 |
In vitro activity of carumonam.
Topics: Anti-Bacterial Agents; Aztreonam; Clindamycin; Drug Synergism; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nafcillin; Piperacillin; Tobramycin | 1985 |
Interaction of Ro 17-2301 (AMA-1080) with beta-lactamases.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Drug Stability; Hydrolysis; Kinetics; Spectrophotometry, Ultraviolet | 1984 |
Interactions between active-site serine beta-lactamases and so-called beta-lactamase-stable antibiotics. Kinetic and molecular modelling studies.
Topics: Actinomycetales; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Binding Sites; Kinetics; Models, Molecular; Serine; Streptomyces | 1993 |
Comparative epileptogenic properties of two monobactam derivatives in C57, Swiss and DBA/2 mice.
Topics: Acoustic Stimulation; Animals; Aztreonam; Cerebral Cortex; Convulsants; Electroencephalography; Injections, Intraventricular; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Monobactams; Seizures | 1996 |
In vitro and in vivo experience with carumonam: a preliminary report.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Clinical Trials as Topic; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 1989 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Chromatography, High Pressure Liquid; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Monte Carlo Method; Plasma; Spectrophotometry, Ultraviolet; Young Adult | 2009 |
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin | 2016 |